Clinical Trial Update: A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating azithromycin prophylaxis to prevent acute chest syndrome in sickle cell disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Sickle Cell Disease, Acute Chest Syndrome | Phase 1 | Status: WITHDRAWN